Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dhodapkar

Showing results (131-140 of 158) with videos related to

Pageof 16
Sort By:
JCI Insight|December 27, 2016
Interlesional diversity of T cell receptors in melanoma with immune checkpoints enriched in tissue-resident memory T cellsChandra Sekhar Boddupalli, Noffar Bar, Krishna Kadaveru, et al.
Bone Marrow Transplantation|January 11, 2005
Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trialS Gupta, P Zhou, H Hassoun, et al.
The Journal of Clinical Investigation|September 13, 2016
ABC transporters and NR4A1 identify a quiescent subset of tissue-resident memory T cellsChandra Sekhar Boddupalli, Shiny Nair, Simon M Gray, et al.
Blood Advances|March 8, 2021
Tandem high-dose influenza vaccination is associated with more durable serologic immunity in patients with plasma cell dyscrasiasAndrew R Branagan, Eamon Duffy, Geliang Gan, et al.
JCI Insight|July 22, 2020
Risk-associated alterations in marrow T cells in pediatric leukemiaJithendra Kini Bailur, Samuel S McCachren, Katherine Pendleton, et al.
Blood Cancer Discovery|August 26, 2022
Changes in Bone Marrow Tumor and Immune Cells Correlate with Durability of Remissions Following BCMA CAR T Therapy in MyelomaKavita M Dhodapkar, Adam D Cohen, Akhilesh Kaushal, et al.
The Journal of Clinical Investigation|August 5, 2025
Early CD4+ T-cell proliferative burst and chronic T-cell engagement impact myeloma outcomes following T-cell engager therapyAlyssa M Duffy, Anshika Goenka, Maryam I Azeem, et al.
NPJ Vaccines|October 28, 2024
Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunityAlberto Moreno, Kelly Manning, Maryam I Azeem, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2023
Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunityAlberto Moreno, Kelly Manning, Maryam I Azeem, et al.
Research Square|October 4, 2023
Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunityAlberto Moreno, Kelly Manning, Maryam I Azeem, et al.
Pageof 16

Showing results (131-140 of 158) with videos related to

Sort By:
Pageof 16
JCI Insight|December 27, 2016
Interlesional diversity of T cell receptors in melanoma with immune checkpoints enriched in tissue-resident memory T cellsChandra Sekhar Boddupalli, Noffar Bar, Krishna Kadaveru, et al.
Bone Marrow Transplantation|January 11, 2005
Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trialS Gupta, P Zhou, H Hassoun, et al.
The Journal of Clinical Investigation|September 13, 2016
ABC transporters and NR4A1 identify a quiescent subset of tissue-resident memory T cellsChandra Sekhar Boddupalli, Shiny Nair, Simon M Gray, et al.
Blood Advances|March 8, 2021
Tandem high-dose influenza vaccination is associated with more durable serologic immunity in patients with plasma cell dyscrasiasAndrew R Branagan, Eamon Duffy, Geliang Gan, et al.
JCI Insight|July 22, 2020
Risk-associated alterations in marrow T cells in pediatric leukemiaJithendra Kini Bailur, Samuel S McCachren, Katherine Pendleton, et al.
Blood Cancer Discovery|August 26, 2022
Changes in Bone Marrow Tumor and Immune Cells Correlate with Durability of Remissions Following BCMA CAR T Therapy in MyelomaKavita M Dhodapkar, Adam D Cohen, Akhilesh Kaushal, et al.
The Journal of Clinical Investigation|August 5, 2025
Early CD4+ T-cell proliferative burst and chronic T-cell engagement impact myeloma outcomes following T-cell engager therapyAlyssa M Duffy, Anshika Goenka, Maryam I Azeem, et al.
NPJ Vaccines|October 28, 2024
Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunityAlberto Moreno, Kelly Manning, Maryam I Azeem, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2023
Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunityAlberto Moreno, Kelly Manning, Maryam I Azeem, et al.
Research Square|October 4, 2023
Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunityAlberto Moreno, Kelly Manning, Maryam I Azeem, et al.
Pageof 16